Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Mythic Therapeutics

Clinical trials sponsored by Mythic Therapeutics, explained in plain language.

New targeted drug tested for Tough-to-Treat lung cancers

Disease control Terminated

This study tested a new type of targeted cancer drug called MYTX-011 in people with advanced non-small cell lung cancer (NSCLC) that had progressed after standard treatments. The main goals were to find a safe dose and see if the drug could shrink tumors, especially in patients w…

Phase: PHASE1 • Sponsor: Mythic Therapeutics • Aim: Disease control

Last updated Mar 13, 2026 15:06 UTC